Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > made the TOP TEN BULLBOARDS Again
View:
Comment by fasttrack5 on Jan 19, 2022 7:08pm
Question is when will we make the top $ 
Comment by 99942Apophis on Jan 19, 2022 9:16pm
fasttrack5 Question is when will we make the top $  I will attempt to answer that question fasttrack5. The answer isn't what you want to hear, if Theralase forms partnerships along their journey as a sole company and maintains a major ownership its top dollar will continue to grow similar to other unique companies that have spread throughout the globe. In my biased opinion I can foresee ...more  
Comment by CancerSlayer on Jan 20, 2022 9:12am
  Let's just break a US dollar for heaven's sake ; )  Actually, you omitted an equally wealth-building opportunity....That is, finally developing this tech/organometallic medicine to become a mainstream option as an antiviral or antibiotic.  The scourge of drug/antibiotic-resistant infections has been a growing crisis for some time now.  Our SOC antibiotics are simply ...more  
Comment by CAinPlap on Jan 20, 2022 9:56am
It would be nice to get an idea of where we are with the work on antivirals/Covid with Dr. Coombes. We haven't heard anything since the announcement last April. Next quarterly maybe?
Comment by 99942Apophis on Jan 20, 2022 10:29am
Yes CancerSlayer you're right on that break the dollar and the rest will follar lol CancerSlayer wrote       Let's just break a US dollar for heaven's sake ; )  Actually, you omitted an equally wealth-building opportunity....That is, finally developing this tech/organometallic medicine to become a mainstream option as an antiviral or antibiotic.  The ...more  
Comment by Lesalpes29 on Jan 20, 2022 10:35am
And we have sellers at .335!
Comment by CAinPlap on Jan 20, 2022 10:45am
And on the other side of the coin, we have buyers at .335. I got 20K on Monday and am jumping through the final hoops to get the proceeds from a house sale to add more. As I mentioned last week, I am hoping the bashers and shorters "Shake harder boy, shake harder" :)
Comment by Lesalpes29 on Jan 20, 2022 10:50am
And yes we have buyers. My last buy at .33 still looking good! Let's go buyers... time is running fast.
Theralase Technologies Inc.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube



INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250